Matthew B. Klein
CEO & DirectorDr. Matthew B. Klein, also known as Matt, M.D., MS, FACS, is Trustee of BioNJ Inc. He serves as Chief Executive Officer and Director of PTC Therapeutics, Inc. since March 24, 2023. He served as an Independent Director at ClearPoint Neuro, Inc. since April 16, 2020 and serves as Director from April 16, 2020. Dr. Klein served as Chief Operating Officer of PTC Therapeutics, Inc. since January 7, 2022 until March 24, 2023 and served as its Chief Development Officer since April 2020 until January 7, 2022. Dr. Klein joined PTC in October 2019 as Global Head of Gene & Mitochondrial Therapies after serving as Chief Executive Officer of BioElectron Technology Corporation from 2018 to 2019 and served as a board member of BioElectron from 2018 to 2020. He served as the Chief Medical Officer of BioElectron from 2013 to 2019 and was Senior Vice President of Clinical Science from 2012 to 2013. He served as Director of BioElectron Technology Corporation. Dr. Klein is a Clinical Associate Professor at Stanford University. He held the David and Nancy Auth-Washington Research Foundation Endowed Chair for Restorative Burn Surgery at the University of Washington where he was a Professor of surgery and epidemiology. His clinical and research expertise spans several fields, including skin biology, wound healing, systemic inflammatory disorders, clinical trials and nutrition. He has authored or co-authored over 80 peer-reviewed manuscripts and 15 book chapters related to these areas and sits on the editorial review boards of several prominent biomedical journals. He has extensive experience in drug discovery and development and a board-certified surgeon. Dr. Klein received his MD degree from Yale University School of Medicine in New Haven, Connecticut and completed his surgical training at Stanford University. Dr. Klein has a BA in History & Chemistry and graduated summa cum laude and phi beta kappa from the University of Pennsylvania in Philadelphia, Pennsylvania. He holds MS in epidemiology from the University Of Washington School Of Public Health.
Positions
- Company NamePTC Therapeutics, Inc.Stock CodePTCTPositionCEO & DirectorColleagues
- MSMichael SchmertzlerIndependent Chairman of the Board
- ASAllan Steven JacobsonCo-Founder & Independent Director
- PGPierre GravierChief Financial Officer
- NANeil AlmsteadChief Technical Operations Officer
- EPEric PauwelsChief Business Officer
- GDGlenn Daniel SteeleIndependent Director
- EREmma ReeveIndependent Director
